L. Rusen

Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors

Barbara A. Konkle, Liselotte S. Ebbesen, Elisabeth Erhardtsen et al. · Journal of Thrombosis and Haemostasis · 2007 · 326 citations · Full text

Medicine, Hematology, Pharmacology +16

Randomized, controlled, parallel-group trial of routine prophylaxis vs. on-demand treatment with sucrose-formulated recombinant factor VIII in adults with severe hemophilia A (SPINART)

Marilyn J. Manco‐Johnson, Christine L. Kempton, Mark T. Reding et al. · Journal of Thrombosis and Haemostasis · 2013 · 198 citations · Full text

Medicine, Hematology, Pharmacotherapy +13

Effect of late prophylaxis in hemophilia on joint status: a randomized trial

Marilyn J. Manco‐Johnson, Björn Lundin, Sharon Funk et al. · Journal of Thrombosis and Haemostasis · 2017 · 127 citations · Full text

Medicine, Hematology, Orthopedic Surgery +13

Multicentre, randomized, open‐label study of on‐demand treatment with two prophylaxis regimens of recombinant coagulation factor IX in haemophilia B subjects

Leonard A. Valentino, L. Rusen, Ivo Elezović et al. · Haemophilia · 2014 · 89 citations

Medicine, Hematology, Pharmacotherapy +14

Prophylaxis vs. on‐demand treatment with BAY 81‐8973, a full‐length plasma protein‐free recombinant factor VIII product: results from a randomized trial (LEOPOLD II)

Renchi Yang, L. Rusen, H. Beckmann et al. · Journal of Thrombosis and Haemostasis · 2014 · 88 citations · Full text

Medicine, Hematology, Pharmacotherapy +13